Login / Signup

Mutations in the anti-sigma H factor RshA confer resistance to econazole and clotrimazole in Mycobacterium smegmatis.

Héctor Ricardo MorbidoniAgustina I de la IglesiaVirginia FigueroaCecilia Beatriz Di CapuaThomas R IoergerTanya Parish
Published in: Access microbiology (2019)
Azole drugs such as econazole, are active on Mycobacterium tuberculosis and Mycobacterium smegmatis ; however, the identification of their target(s) is still pending. It has been reported that mutations in the non-essential system mmpL5-mmpS5 conferred resistance to econazole in M. tuberculosis . We herein report that an azole-resistant mutant screen in M. smegmatis rendered mutations in rshA, encoding a non-essential anti-sigma H protein.
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • candida albicans
  • high throughput
  • emergency department
  • bioinformatics analysis